LD-2 disclosure · 1st Quarter - Report
REGENERON PHARMACEUTICALS, INC
Client
- Location
- New York · United States of America
Registrant
- Description
- Biopharmaceutical development and manufacturing
- Location
- TARRYTOWN, New York, United States of America
Lobbying activities
3 issuesMedicare/Medicaid
Medicare, Medicaid, and other drug pricing issues relating to biopharmaceutical manufacturers
LobbyistsVALERIE VOLPE · KATHERINE HADDAD · MADDIE DAVIDSON · EBEN DUROSS
TargetedSENATE · HOUSE OF REPRESENTATIVES
Copyright/Patent/Trademark
Patent issues relating to biopharmaceutical manufacturers; intellectual property rights; issues related to WTO TRIPS waivers
LobbyistsVALERIE VOLPE · MADDIE DAVIDSON · EBEN DUROSS
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
Biodefense, FDA, and privacy issues relating to biopharmaceutical manufacturers; tax and incentives; issues related to drug manufacturing and pricing; H.R.5376 - Inflation Reduction Act of 2022; H.R.7900 - National Defense Authorization Act for Fiscal Year 2023; S.954 - Affordable Insulin Now Act of 2023; Consolidated Appropriations Act, 2023; issues related to the Prescription Drug User Fee Act
LobbyistsMAYA BERMINGHAM · VALERIE VOLPE · KATHERINE HADDAD · MADDIE DAVIDSON · EBEN DUROSS
SENATE · HOUSE OF REPRESENTATIVES